Seattle Genetics Inc (NASDAQ:SGEN)

74.01
Delayed Data
As of Sep 20
 +1.23 / +1.69%
Today’s Change
50.71
Today|||52-Week Range
84.37
+30.62%
Year-to-Date

Today’s Trading

Previous close72.78
Today’s open73.15
Day’s range72.70 - 74.39
Volume1,479,263
Average volume (3 months)872,717
Market cap$11.9B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)-60.51%
Earnings growth (this year)+6.65%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+35.76%
P/E ratioNM
Price/Sales13.64
Price/Book8.89

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV0.000.00%
ALNYAlnylam Pharmaceutic...+1.90+2.25%
IONSIonis Pharmaceutical...-0.23-0.37%
GLPGGalapagos NV+2.15+1.35%
Data as of 4:00pm ET, 09/20/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$654.7M
Annual profit (last year)-$222.7M
Net profit margin-34.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Financial &
Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts